Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Separate assessment of the activity of each cetuximab maintenance therapy (500 mg/m² every 2 weeks and 250 mg/m² every week) in terms of overall survival time from inclusion in the trial to death in subjects with advanced NSCLC who are free of progression after having received cetuximab in combination with a platinum doublet chemotherapy as first-line treatment.